2-232747282-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_001103146.3(GIGYF2):c.42-333A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.162 in 152,126 control chromosomes in the GnomAD database, including 2,598 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.16 ( 2598 hom., cov: 32)
Consequence
GIGYF2
NM_001103146.3 intron
NM_001103146.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.49
Publications
1 publications found
Genes affected
GIGYF2 (HGNC:11960): (GRB10 interacting GYF protein 2) This gene contains CAG trinucleotide repeats and encodes a protein containing several stretches of polyglutamine residues. The encoded protein may be involved in the regulation of tyrosine kinase receptor signaling. This gene is located in a chromosomal region that was genetically linked to Parkinson disease type 11, and mutations in this gene were thought to be causative for this disease. However, more recent studies in different populations have been unable to replicate this association. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013]
GIGYF2 Gene-Disease associations (from GenCC):
- Parkinson disease 11, autosomal dominant, susceptibility toInheritance: AD, Unknown Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 2-232747282-A-G is Benign according to our data. Variant chr2-232747282-A-G is described in ClinVar as [Benign]. Clinvar id is 1183659.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.216 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.163 AC: 24703AN: 152008Hom.: 2601 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
24703
AN:
152008
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.162 AC: 24693AN: 152126Hom.: 2598 Cov.: 32 AF XY: 0.163 AC XY: 12140AN XY: 74352 show subpopulations
GnomAD4 genome
AF:
AC:
24693
AN:
152126
Hom.:
Cov.:
32
AF XY:
AC XY:
12140
AN XY:
74352
show subpopulations
African (AFR)
AF:
AC:
1762
AN:
41548
American (AMR)
AF:
AC:
2540
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
AC:
981
AN:
3466
East Asian (EAS)
AF:
AC:
585
AN:
5172
South Asian (SAS)
AF:
AC:
446
AN:
4820
European-Finnish (FIN)
AF:
AC:
2898
AN:
10550
Middle Eastern (MID)
AF:
AC:
55
AN:
292
European-Non Finnish (NFE)
AF:
AC:
14881
AN:
67990
Other (OTH)
AF:
AC:
410
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
996
1991
2987
3982
4978
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
373
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.